推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

LANCET

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 LANCET最新评论:请问,lancet (correspondence)投稿后都会收到acknowledge吗?投稿一个月了,没有收到acknowledge,而且仍在with editor状态。... (2024-10-11)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
出版社推荐:美国化学会ACS期刊一览IF 2.9,JCR Q2 神经系统基础研究期刊征稿中开放获取选刊时如何避雷?点击查看干货指南!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


LANCET期刊基本信息Hello,您是该期刊的第215089位访客


基本信息 登录收藏
期刊名字LANCETLANCET

LANCET
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.7
64人评分
我要评分

声誉
9.8

影响力
9.8

速度
9.2

期刊ISSN0140-6736
微信扫码收藏此期刊
E-ISSN1474-547X
2023-2024最新影响因子
(数据来源于搜索引擎)
98.4 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:57.488
2023-2024自引率1.10%点击查看自引率趋势图
五年影响因子106.9
JCI期刊引文指标 24.06
h-index 700
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
148.1012.11323.150
学科分区排名百分位
大类:Medicine
小类:General Medicine
Q11 / 636

期刊简介
The Lancet is an international general medical journal that will consider any original contribution that advances or illuminates medical science or practice, or that educates or entertains the journal's readers. Whatever you have written, remember that it is the general reader whom you are trying to reach. One way to find out if you have succeeded is to show your draft to colleagues in other specialties. If they do not understand, neither, very probably, will The Lancet's staff or readers. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal.
期刊官方网站http://www.thelancet.com/
期刊投稿网址https://www.editorialmanager.com/THELANCET
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足LANCET的语言要求,还能让LANCET编辑和审稿人得到更好的审稿体验,让稿件最大限度地被LANCET编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
出版商Elsevier Ltd
涉及的研究方向医学-医学:内科
出版国家或地区ENGLAND
出版语言English
出版周期Weekly
出版年份1823
年文章数 218点击查看年文章数趋势图
Gold OA文章占比25.97%
研究类文章占比:
文章 ÷(文章 + 综述)
76.15%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:MEDICINE, GENERAL & INTERNALSCIEQ11/325
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:MEDICINE, GENERAL & INTERNALSCIEQ12/329
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
MEDICINE, GENERAL & INTERNAL
医学:内科
4区1区1区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
MEDICINE, GENERAL & INTERNAL
医学:内科
1区3区1区
中国科学院SCI期刊分区
2021年12月旧的升级版
(没有被旧的JCR升级版收录,仅供参考)
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0140-6736%5BISSN%5D
平均审稿速度网友分享经验:
平均3月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在LANCET顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 LANCET期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 LANCET中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
LANCET上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62248.20
    ANNALS OF INTERNAL MEDICINE35923.90
    Annual Review of Medicine14824.90
    PLOS MEDICINE19721.60
    CANADIAN MEDICAL ASSOCIATION JOURNAL1688.30
    JOURNAL OF TRAVEL MEDICINE5120.90
    JOURNAL OF INTERNAL MEDICINE14322.00
    Cochrane Database of Systematic Reviews24410.60
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE718.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE681783
    BIOMATERIALS569864
    BIOMEDICINE & PHARMACOTHERAPY555446
    Frontiers in Pharmacology519033
    Journal of Materials Chemistry B512717
    Frontiers in Immunology496225
    COMPUTERS IN BIOLOGY AND MEDICINE478669
    JOURNAL OF ETHNOPHARMACOLOGY469882
    COLLOIDS AND SURFACES B-BIOINTERFACES440618
    Frontiers in Oncology439242
  •  

    LANCET LANCET
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

    Author: Hurvitz, Sara A.; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier
    Journal: LANCET. 2023; Vol. 401, Issue 10371, pp. 105-117. DOI: 10.1016/S0140-6736(22)02420-5
        PubMed      DOI
    2.Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferioritytrial

    Author: Wang, Yongjun; Li, Shuya; Pan, Yuesong; Li, Hao; Parsons, Mark W.; Campbell, Bruce C., V; Schwamm, Lee H.; Fisher, Marc; Che, Fengyuan; Dai, Hongguo; Li, Deyang; Li, Runhui; Wang, Junhai; Wang, Yilong; Zhao, Xingquan; Li, Zixiao; Zheng, Huaguang; Xiong, Yunyun; Meng, Xia
    Journal: LANCET. 2023; Vol. 401, Issue 10377, pp. 645-654. DOI: 10.1016/S0140-6736(22)02600-9
        PubMed      DOI
    3.Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

    Author: Pan, Yang; Wang, Liang; Feng, Zhaomin; Xu, Hui; Li, Fu; Shen, Ying; Zhang, Daitao; Liu, William J.; Gao, George F.; Wang, Quanyi
    Journal: LANCET. 2023; Vol. 401, Issue 10377, pp. 664-672. DOI: 10.1016/S0140-6736(23)00129-0
        PubMed      DOI
    4.Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

    Author: Kimball, Alexa B.; Jemec, Gregor B. E.; Alavi, Afsaneh; Reguiai, Ziad; Gottlieb, Alice B.; Bechara, Falk G.; Paul, Carle; Bourboulis, Evangelos J. Giamarellos; Villani, Axel P.; Schwinn, Andreas; Rueff, Franziska; Ramaya, Larisha Pillay; Reich, Adam; Lobo, Ines; Sinclair, Rodney; Passeron, Thierry; Martorell, Antonio; Mendes-Bastos, Pedro; Kokolakis, Georgios; Becherel, Pierre-Andre; Wozniak, Magdalena B.; Martinez, Angela Llobet; Wei, Xiaoling; Uhlmann, Lorenz; Passera, Anna; Keefe, Deborah; Martin, Ruvie; Field, Clarice; Chen, Li; Vandemeulebroecke, Marc; Ravichandran, Shoba; Muscianisi, Elisa
    Journal: LANCET. 2023; Vol. 401, Issue 10378, pp. 747-761. DOI: 10.1016/S0140-6736(23)00022-3
        PubMed      DOI
    5.Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

    Author: You, Rui; Liu, You -Ping; Xie, Yu -Long; Lin, Chao; Duan, Chong -Yang; Chen, Dong-Ping; Pan, Yi; Qi, Bin; Zou, Xiong; Guo, Ling; Cao, Jing-Yu; Zhang, Yi-Nuan; Wang, Zhi-Qiang; Liu, Yong -Long; Ouyang, Yan-Feng; Wen, Kai; Yang, Qi; Xie, Ruo-Qi; Li, Hui-Feng; Duan, Xiao-Tong; Ding, Xi; Peng, Lan; Chen, Si -Yuan; Liang, Jiong-Lin; Feng, Zheng-Kai; Xia, Tian-Liang; Xie, Rui-Ling; Jiang, Rou; Gu, Chen-Mei; Liu, Rong-Zeng; Sun, Rui; Yang, Xin; Liu, Li-Zhi; Ling, Li; Liu, Qing; Ng, Wai Tong; Hua, Yi-Jun; Huang, Pei-Yu; Chen, Ming-Yuan
    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 917-927. DOI: 10.1016/S0140-6736(23)00269-6
        PubMed      DOI
    6.Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomisedtrial

    Author: He, Jiang; Ouyang, Nanxiang; Guo, Xiaofan; Sun, Guozhe; Li, Zhao; Mu, Jianjun; Wang, Dao Wen; Qiao, Lixia; Xing, Liying; Ren, Guocheng; Zhao, Chunxia; Yang, Ruihai; Yuan, Zuyi; Wang, Chang; Shi, Chuning; Liu, Songyue; Miao, Wei; Li, Guangxiao; Chen, Chung-Shiuan; Sun, Yingxian; CRHCP Study Grp
    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 928-938. DOI: 10.1016/S0140-6736(22)02603-4
        PubMed      DOI
    7.Malnutrition in older adults

    Author: Dent, Elsa; Wright, Olivia R. L.; Woo, Jean; Hoogendijk, Emiel O.
    Journal: LANCET. 2023; Vol. 401, Issue 10380, pp. 951-966. DOI: 10.1016/S0140-6736(22)02612-5
        PubMed      DOI
    8.Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial

    Author: Mingguang He, Yuzhen Jiang, Shengsong Huang, Dolly S Chang, Beatriz Munoz, Tin Aung, Paul J Foster, David S Friedman
    Journal: LANCET, 2019, Vol., , DOI:10.1016/s0140-6736(18)32607-2
        DOI
    9.The KEYNOTE-061 trial

    Author: Fei Liang
    Journal: LANCET, 2019, Vol.393, 1098, DOI:10.1016/s0140-6736(18)33073-3
        DOI
    10.Strengthening the legal framework to regulate human genetic engineering in China

    Author: Cao Yanlin, Zheng Xueqian, Jia Fei
    Journal: LANCET, 2019, Vol.393, 1097, DOI:10.1016/s0140-6736(19)30294-6
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62248.20
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共145


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室